For NF1-negative controls, we included a CRISPR-mediated NF1 knockout MCF7 line (9) and two naturally-occurring NF1-null cell lines: the ER– breast cancer cell line MDA-MB-231 (9) and an ovarian cancer cell line OVCA429 (11). The gene discussed is NF1; the disease is breast cancer.